We followed the changes in the activities of four enzymes (aldolase, aspartate aminotransferase, creatine kinase, and lactate dehydrogenase) in plasma for four days after head injury. 
Materials and Methods

Study population:
The total number of cases was 346. The learning sample (L.S.),266 patients with clinical complications (see below, "Clinical signs"), was studied so that we could establish discriminant functions between survivors (n = 55) and nonsurvivors (n = 11). The testing sample (T.S.) consisted of 280 patients, selected without conscious bias, who were admitted for head injury with loss of consciousness. Clinical signs: All the L.S. patients had severe head injury with loss of consciousness and clinical complications (coma, skull fracture, intracranial edema, and (or) hematoma). The clinical signs for the T.S. patients (Table 1) were more intensively studied and were used to try to explain possible misclassification.
Statistical and prognostic analysis:
For the L.S. we first used Student's t-test (8) . The differences between the two groups were significant when p We then used the program) with the following four parameters. First, we calculated the cumulative probabilities for discriminating the two groups, taking into account ASAT, ASAT + CK, ASAT + CK + ALD, and ASAT + CK + ALD + LD ( Table   2 ). Next, we calculated discriminant functions from the activities of these four sets of enzymes at 72 and 96 h after injury. The validity of the functions based on the last set was blindly tested with the T.S. population (Table 3) and evaluated in terms of sensibility (well-predicted survivors), specificity (well-predicted nonsurvivors), and efficiency (total of well-classified patients) according to Galen and Gambino (10) and Henderson and Nealon (11).
Discussion
We chose to study enzymatic activities because of their rapid variations in plasma. We preferred to use plasma rather than cerebrospinal fluid because successive samplings would be without risk to the patient. Cerebrospinal fluid sampling may be dangerous in intracranial edema. Activities of these enzymes considered separately are not specific for head injury. In fact they also are used to detect cardiac diseases (12, 13, 14) or muscular diseases
(15).
However our results demonstrated that, combined, they may increase the predictive value of the clinical progression or outcome of a head injury ( Table 2) . Activities of these four enzymes-but not of alkaline phosphatase, a-amylase, yglutamyltransferase, glutamate dehydrogenase, or alanine aminotransferase-significantly differed between survivor and nonsurvivor groups some time after the trauma. However, changes in ALD and LD seem to appear earlier than those in ASAT or CK. Thus, the prognostic value of each enzyme may differ but combining such information may increase its prognostic value. By trying discriminant analysis, so as to have the most efficient information with the minimum of biochemical determinations, the efficiency of our approach was fairly good. In fact, we found that discrimination was better at 72 h than at 96 h for the four variables combined.
We also observed that head injury without clinical complication does not increase the activities of these enzymes in plasma (unpublished data).
Inclusion of ALD activity significantly increases the efficiency of discrimination. Further studies are now under way to examine whether it is a more specific enzyme for head injury. Table 4 lists the main clinical characteristics of misclassified patients. We observed that phenobarbital sedation according to Gobiet (16) was a common feature in survivors whose enzyme data indicated an unfavorable prognosis, although we cannot affirm that this therapy changed their clinical course. Those patients who died despite a favorable enzymatic prognosis often had intracranial disorders (edema or hematoma). More cases must be studied to elucidate the origins of misclassification.
Concentrations of acute-phase proteins (especially C-reactive protein) in serum increase quickly and significantly in head injury complicated with edema or hematoma (17, 18) .
Although this protein is not specific for cerebral edema or hematoma, such data added to the data on enzymatic activities might increase the efficiency of prognosis. We also have further studies under way to examine this possibility. Do these enzymatic activities come from cerebral or peripheral cells? For CK, Jung and Ferard (19) showed that, in trauma cases, the BB isoenzyme represented only 2% of the total CK activity in plasma; most was the MM isoenzyme, which is mainly concentrated in muscle cells. The mechanism of this enzyme release is still to be explained.
We conclude that, when these four enzymes' activities are measured, the prognosis for head-injured patients can be made more reliably. We could distinguish survivors from nonsurvivors with an efficiency ranging between 81 and 92%. We believe that these activities should be measured daily and compared with other biochemical or clinical data for the greatest efficiency. 
